Involvement of eosinophils in the anti-tumor response
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Eosinophils have long been associated with allergy and parasitic infections. Today, they are considered as multifunctional leukocytes, which participate both in innate and adaptive immune response though the expression of various receptors and mediators. Although the tumor-associated eosinophilia is observed for a long time in many hematological and solid malignancies, with a generally good prognosis value, there is a lack of knowledge on the different mechanisms involved in this phenomenon. Moreover, the recent discovery in human eosinophils of different receptors and mediators, shared with lymphocytes and involved in anti-tumor defense, suggests that eosinophils can play a role in anti-tumoral immunity. We review in the present paper the current knowledge on epidemiology, recruitment, and mechanisms involved in the response of eosinophils toward tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Considering that eosinophils can have a role in the response against cancer,17–20 an elevated AEC might be a marker of effectiveness in some patients.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rothenberg, M. E., & Hogan, S. P. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090720 · Cited by 1,356
Eosinophils: Biological Properties and Role in Health and Disease
HOGAN, S. P., ROSENBERG, H. F., MOQBEL, R., PHIPPS, S., FOSTER, P. S., LACY, P., KAY, A. B., & ROTHENBERG, M. E. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.02958.x · Cited by 834
Mechanisms of eosinophil-associated inflammation
Gleich, G. J. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.105712 · Cited by 785
An Eosinophil-Dependent Mechanism for the Antitumor Effect of Interleukin-4
Tepper, R. I., Coffman, R. L., & Leder, P. (1992) · Science · doi:10.1126/science.1636093 · Cited by 541
High-affinity IgE receptor on eosinophils is involved in defence against parasites
Soussi Gounni, A., Lamkhioued, B., Ochiai, K., Tanaka, Y., Delaporte, E., Capron, A., Kinet, J.-P., & Capron, M. (1994) · Nature · doi:10.1038/367183a0 · Cited by 517
Self-citationYang, D., Chen, Q., Su, S. B., Zhang, P., Kurosaka, K., Caspi, R. R., Michalek, S. M., Rosenberg, H. F., Zhang, N., & Oppenheim, J. J. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20062027 · Cited by 352
Eosinophils: multifaceted biological properties and roles in health and disease
Kita, H. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01026.x · Cited by 336
Eosinophils in health and disease: the LIAR hypothesis
Lee, J. J., Jacobsen, E. A., McGarry, M. P., Schleimer, R. P., & Lee, N. A. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03484.x · Cited by 334
Ikutani, M., Yanagibashi, T., Ogasawara, M., Tsuneyama, K., Yamamoto, S., Hattori, Y., Kouro, T., Itakura, A., Nagai, Y., Takaki, S., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101270 · Cited by 314
Immunotherapy of Cytotoxic T Cell–resistant Tumors by T Helper 2 Cells
Mattes, J., Hulett, M., Xie, W., Hogan, S., Rothenberg, M. E., Foster, P., & Parish, C. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021683 · Cited by 256
Tumour-associated eosinophilia: a review.
Lowe, D., Jorizzo, J., & Hutt, M. S. (1981) · Journal of Clinical Pathology · doi:10.1136/jcp.34.12.1343 · Cited by 255
Simson, L., Ellyard, J. I., Dent, L. A., Matthaei, K. I., Rothenberg, M. E., Foster, P. S., Smyth, M. J., & Parish, C. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4222 · Cited by 216
AllergoOncology: the role of IgE‐mediated allergy in cancer
Jensen‐Jarolim, E., Achatz, G., Turner, M. C., Karagiannis, S., Legrand, F., Capron, M., Penichet, M. L., Rodríguez, J. A., Siccardi, A. G., Vangelista, L., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01768.x · Cited by 216
Self-citationEosinophils and Th2 immunity: contemporary insights
Spencer, L. A., & Weller, P. F. (2010) · Immunology & Cell Biology · doi:10.1038/icb.2009.115 · Cited by 213
Eosinophil infiltration of human colonic carcinomas as a prognostic indicator.
Pretlow, T. P., Keith, E. F., Cryar, A., Bartolucci, A., Pitts, A. M., Pretlow, T. G., KIMBALL, P. M., & Boohaker, E. A. (1983) · PubMed · Cited by 207
Eosinophils: ‘new’ roles for ‘old’ cells
Munitz, A., & Levi‐Schaffer, F. (2004) · Allergy · doi:10.1111/j.1398-9995.2003.00442.x · Cited by 196
von Wasielewski, R., Seth, S., Franklin, J., Fischer, R., Hübner, K., Hansmann, M. L., Diehl, V., & Georgii, A. (2000) · Blood · doi:10.1182/blood.v95.4.1207.004k34_1207_1213 · Cited by 191
Cormier, S. A., Taranova, A. G., Bedient, C., Nguyen, T., Protheroe, C., Pero, R., Dimina, D., Ochkur, S. I., O’Neill, K., Colbert, D., et al. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0106027 · Cited by 176
Legrand, F., Driss, V., Delbeke, M., Loiseau, S., Hermann, E., Dombrowicz, D., & Capron, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000446 · Cited by 176
Self-citationPrognostic influence of tumor‐associated eosinophilic infiltrate in colorectal carcinoma
Fernández‐Aceñero, M. J., Galindo‐Gallego, M., Sanz, J., & Aljama, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000401)88:7<1544::aid-cncr7>3.3.co;2-j · Cited by 175
Lotfi, R., Lee, J. J., & Lotze, M. T. (2007) · Journal of Immunotherapy · doi:10.1097/01.cji.0000211324.53396.f6 · Cited by 167
Mature human eosinophils have the capacity to express HLA-DR.
Lucey, D. R., Nicholson-Weller, A., & Weller, P. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1348 · Cited by 163
Is atopy a protective or a risk factor for cancer? A review of epidemiological studies
Wang, H., & Diepgen, T. L. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00813.x · Cited by 162
Tumour‐associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas
Dorta, R. G., Landman, G., Kowalski, L. P., Lauris, J. R. P., Latorre, M. R. D. O., & Oliveira, D. T. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.01437.x · Cited by 161
Tomassini, M., Tsicopoulos, A., Tai, P. C., Gruart, V., Tonnel, A.-B., Prin, L., Capron, A., & Capron, M. (1991) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(91)90099-a · Cited by 158
Self-citationAn overview of the association between allergy and cancer
Turner, M. C., Chen, Y., Krewski, D. R., & Ghadirian, P. (2006) · International Journal of Cancer · doi:10.1002/ijc.21752 · Cited by 156
Teruya‐Feldstein, J., Jaffe, E. S., Burd, P. R., Kingma, D. W., Setsuda, J., & Tosato, G. (1999) · Blood · doi:10.1182/blood.v93.8.2463.408k02_2463_2470 · Cited by 147
Pinto, A., Aldinucci, D., Gloghini, A., Zagonel, V., Degan, M., Improta, S., Juzbasic, S., Todesco, M., Perin, V., Gattei, V., et al. (1996) · Blood · doi:10.1182/blood.v88.9.3299.bloodjournal8893299 · Cited by 143
Dibbert, B., Daigle, I., Braun, D., Schranz, C., Weber, M., Blaser, K., Zangemeister-Wittke, U., Akbar, A. N., & Simon, H.-U. (1998) · Blood · doi:10.1182/blood.v92.3.778 · Cited by 143
Serum Interleukin-33 Levels in Patients with Gastric Cancer
Sun, P., Ben, Q., Tu, S., Dong, W., Qi, X., & Wu, Y. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1760-5 · Cited by 130
2B4 (CD244) Is Expressed and Functional on Human Eosinophils
Munitz, A., Bachelet, I., Fraenkel, S., Katz, G., Mandelboim, O., Simon, H., Moretta, L., Colonna, M., & Levi‐Schaffer, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.110 · Cited by 121
IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo
Benatar, T., Cao, M. Y., Lee, Y., Lightfoot, J., Feng, N., Gu, X., Lee, V., Jin, H., Wang, M., Wright, J. A., et al. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0802-8 · Cited by 111
Eosinophils Oxidize Damage-Associated Molecular Pattern Molecules Derived from Stressed Cells
Lotfi, R., Herzog, G. I., DeMarco, R. A., Beer-Stolz, D., Lee, J. J., Rubartelli, A., Schrezenmeier, H., & Lotze, M. T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900504 · Cited by 111
Cytolytic cells induce HMGB1 release from melanoma cell lines
Ito, N., DeMarco, R. A., Mailliard, R. B., Han, J., Rabinowich, H., Kalinski, P., Stolz, D. B., Zeh, H. J., & Lotze, M. T. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306169 · Cited by 99
Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils
Stenfeldt, A., & Wennerås, C. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01906.x · Cited by 97
TLR2-dependent eosinophil interactions with mycobacteria: role of α-defensins
Driss, V., Legrand, F., Hermann, E., Loiseau, S., Guérardel, Y., Kremer, L., Adam, E., Woerly, G., Dombrowicz, D., & Capron, M. (2008) · Blood · doi:10.1182/blood-2008-07-166595 · Cited by 96
Self-citationTumor-associated tissue eosinophilia in human esophageal squamous cell carcinoma.
Ishibashi, S., Ohashi, Y., Suzuki, T., Miyazaki, S., Moriya, T., Satomi, S., & Sasano, H. (2006) · PubMed · Cited by 90
Fujii, M., Yamashita, T., Ishiguro, R., Tashiro, M., & Kameyama, K. (2002) · Auris Nasus Larynx · doi:10.1016/s0385-8146(01)00135-3 · Cited by 89
Abu-Ghazaleh, R. I., Gleich, G. J., & Prendergast, F. G. (1992) · The Journal of Membrane Biology · doi:10.1007/bf00231888 · Cited by 83
Rivoltini, L., Colombo, M. P., Parmiani, G., Viggiano, V., Spinazzé, S., Santoro, A., & Takatsu, K. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540103 · Cited by 78
Interleukin‐2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome
Simon, H., Plötz, S., Simon, D., Seitzer, U., Braathen, L. R., Menz, G., Straumann, A., Dummer, R., & Levi‐Schaffer, F. (2003) · European Journal of Immunology · doi:10.1002/eji.200323727 · Cited by 76
Huland, E., & Huland, H. (1992) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01629431 · Cited by 70
A Functional γδTCR/CD3 Complex Distinct from γδT Cells Is Expressed by Human Eosinophils
Legrand, F., Driss, V., Woerly, G., Loiseau, S., Hermann, E., Fournié, J., Héliot, L., Mattot, V., Soncin, F., Gougeon, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005926 · Cited by 67
Self-citationGeisinger, K. R., Steffee, C. H., McGee, R. S., Woodruff, R. D., & Buss, D. H. (1998) · American Journal of Clinical Pathology · doi:10.1093/ajcp/109.3.294 · Cited by 59
Éosinophiles et réponse antitumorale
Costello, R. T., O'Callaghan, T., & Sébahoun, G. (2005) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2005.02.013 · Cited by 58
Lorena, S., Oliveira, D., Dorta, R., Landman, G., & Kowalski, L. (2003) · Oral Diseases · doi:10.1034/j.1601-0825.2003.00958.x · Cited by 58
Sosman, J. A., Bartemes, K. R., Offord, K. P., Kita, H., Fisher, S. G., Kefer, C., Ellis, T. A., Fisher, R. I., Higgins, T., & Gleich, G. J. (1995) · PubMed · Cited by 50
Jönsson, U., Byström, J., Stålenheim, G., & Venge, P. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2002.01410.x · Cited by 49
Caruso, R. A., Parisi, A., Quattrocchi, E., Scardigno, M., Branca, G., Parisi, C., Lucianò, R., Paparo, D., & Fedele, F. (2011) · Ultrastructural Pathology · doi:10.3109/01913123.2011.578233 · Cited by 49
Tumor‐associated tissue eosinophilia of penile cancer
Ono, Y., Ozawa, M., Tamura, Y., Suzuki, T., Suzuki, K., Kurokawa, K., Fukabori, Y., & Yamanaka, H. (2002) · International Journal of Urology · doi:10.1046/j.1442-2042.2002.00424.x · Cited by 43
Luna-Moré, S., Florez, P., Ayala, A., Diaz, F., & Santos, A. (1997) · Pathology - Research and Practice · doi:10.1016/s0344-0338(97)80006-4 · Cited by 40
TARC and IL-5 expression correlates with tissue eosinophilia in peripheral T-cell lymphomas
Thielen, C., Radermacher, V., Trimèche, M., Roufosse, F. E., Goldman, M., Boniver, J., & de Leval, L. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.02.016 · Cited by 37
Bystander Cells and Prognosis in Hodgkin Lymphoma
Molin, D. (2004) · Upsala Journal of Medical Sciences · doi:10.3109/2000-1967-084 · Cited by 29
Metastatic Carcinoma Presenting with Concomitant Eosinophilia and Thromboembolism
Fridlender, Z. G., Shalit, M., & Simon, H. (2003) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200308000-00008 · Cited by 25
Koyanagi, K., Ozawa, S., Ando, N., Mukai, M., Kitagawa, Y., Ueda, M., & Kitajima, M. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000401)88:7<1530::aid-cncr5>3.0.co;2-4 · Cited by 21
Cited by
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Carretero, R., Sektioglu, I. M., Garbi, N., Salgado, O. C., Beckhove, P., & Hämmerling, G. J. (2015) · Nature Immunology · doi:10.1038/ni.3159 · Cited by 501
Eosinophil Cytokines, Chemokines, and Growth Factors: Emerging Roles in Immunity
Davoine, F., & Lacy, P. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00570 · Cited by 353
A new dawn for eosinophils in the tumour microenvironment
Grisaru-Tal, S., Itan, M., Klion, A. D., & Munitz, A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0283-9 · Cited by 302
Eosinophils: The unsung heroes in cancer?
Varricchi, G., Galdiero, M. R., Loffredo, S., Lucarini, V., Marone, G., Mattei, F., Marone, G., & Schiavoni, G. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1393134 · Cited by 280
Metadata
- Authors
- Gatault, S., Legrand, F., Delbeke, M., Loiseau, S., & Capron, M.
- Affiliations
- Inserm (FR)
- National Institutes of Health (US)
- Corresponding author
- Gatault, Solène
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 2012-06-17
- Volume
- 61
- Issue
- 9
- Pages
- 1527-1534
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- PMC
- PMC11029779
- OpenAlex
- W2036123202
- Semantic Scholar
- 3afbb404c341e46dd8b82da492afaf7b19ae9c5e
- Cited by
- 132
- References
- 54
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 11 · 2023: 10 · 2022: 8 · 2021: 13 · 2020: 10 · 2019: 14 · 2018: 9 · 2017: 13 · 2016: 10 · 2015: 7 · 2014: 6 · 2013: 7 · 2012: 1
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cancer Immunology Immunotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- eosinophils, antitumor immunity, eosinophil recruitment, innate and adaptive immunity, hematologic malignancies, solid tumors, prognosis
- MeSH terms
- Animals, Eosinophils, Humans, Immunity, Innate, Neoplasms, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.